Medical Science Liaison (MSL) Neurology Mid Atlantic
Vor Bio
About this role
Vor is hiring a Neurology Medical Science Liaison (MSL) for the Mid Atlantic region to support the development of telitacicept, a dual BAFF/APRIL inhibitor, in autoimmune disease with an initial focus on generalized myasthenia gravis. The role is field-based with extensive travel and serves as a key scientific interface between Vor and external neurology stakeholders. The position reports to the National Executive Director.
Skills
Qualifications
About Vor Bio
vorbio.comVor Bio is a clinical-stage cell and genome engineering company developing novel hematopoietic stem cell-based therapies for cancer. The company is focused on transforming the treatment of hematological malignancies through engineered stem cell transplantation and targeted therapeutics.
Recent company news
JPM26: Vor Bio narrows focus to two-indication strategy
Jan 15, 2026
Vor Bio's surprise $4B revival deal for RemeGen's autoimmune drug triggers divergent stock reactions
Jun 26, 2025
Vor Bio Announces $150 Million Private Placement
Dec 15, 2025
Vor, with new CEO, changes course to target autoimmune disease
Jun 26, 2025
Vor Bio to wind down, halting cell therapy trials and shedding most staff
May 8, 2025
About Vor Bio
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Vor Bio.
Salary
$208k – $255k
per year
More jobs at Vor Bio
Similar Jobs
Medical Science Liaison, MS - Mid-Atlantic
Sanofi
Medical Science Liaison (MSL) Neuroscience
Eli Lilly and Company
Medical Director, Neurology, Medical Affairs
AstraZeneca
Medical Science Liaison (MSL)/Sr. MSL - Mid-Atlantic
Genmab
Medical Science Liaison (MSL) Neuroscience
Eli Lilly and Company
Medical Director, Global Medical Affairs, Rare Disease
Amgen